Immatics Biotechnologies immatics.com


Public lists: BIO 2016 (619)

immatics biotechnologies is a clinical-stage biopharmaceutical company leading the development of advanced immunotherapies that are active against cancer. immatics' lead product, IMA901, is in a pivotal phase 3 study after completing a successful randomised phase 2 trial in renal cell carcinoma. immatics' pipeline also includes IMA910, which has reported encouraging overall survival data in patients with advanced colorectal cancer, and IMA950, which has completed a phase 1 study in patients with...Show all

immatics biotechnologies is a clinical-stage biopharmaceutical company leading the development of advanced immunotherapies that are active against cancer. immatics' lead product, IMA901, is in a pivotal phase 3 study after completing a successful ran...Show all

Company (Alive / Active)

Phone: +49 (7071) 5397-0

Fax:

Paul-Ehrlich-Str. 15

Tuebingen, D-72076
Germany

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Immatics Biotechnologies $220.4M Jan 9, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Immatics Biotechnologies Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 17 investors
There is no Competitors data available for this company. Please select another tab.